Levetiracetam in Alzheimer's Disease: Do Epileptologists Already Have the Cure?

Affiliations

Comment

Rani A Sarkis. Epilepsy Curr. 2022.

. 2022 Jul 16;22(4):225-227.

doi: 10.1177/15357597221096020. eCollection 2022 Jul-Aug.

Erratum in

Erratum 22(1), 22(2), 22(3) and 22(4).
[No authors listed] [No authors listed] Epilepsy Curr. 2022 Dec 1;23(1):61-62. doi: 10.1177/15357597221144381. eCollection 2023 Jan-Feb. Epilepsy Curr. 2022. PMID: 36923327 Free PMC article.

No abstract available

Effect of Levetiracetam on Cognition in Patients With Alzheimer Disease With and Without Epileptiform Activity: A Randomized Clinical Trial.
Vossel K, Ranasinghe KG, Beagle AJ, La A, Ah Pook K, Castro M, Mizuiri D, Honma SM, Venkateswaran N, Koestler M, Zhang W, Mucke L, Howell MJ, Possin KL, Kramer JH, Boxer AL, Miller BL, Nagarajan SS, Kirsch HE. Vossel K, et al. JAMA Neurol. 2021 Nov 1;78(11):1345-1354. doi: 10.1001/jamaneurol.2021.3310. JAMA Neurol. 2021. PMID: 34570177 Free PMC article. Clinical Trial.

1. 2022 Alzheimer’s Disease Facts and Figures. Alzheimers Dement. 2022. - PubMed
1. Palop JJ, Mucke L. Network abnormalities and interneuron dysfunction in Alzheimer disease. Nat Rev Neurosci. 2016; 17(12): 777-792. - PMC - PubMed
1. Lam AD, Sarkis RA, Pellerin KR, et al. Association of epileptiform abnormalities and seizures in Alzheimer disease. Neurology. 2020; 95(16): e2259-e2270. - PMC - PubMed
1. Vossel KA, Ranasinghe KG, Beagle AJ, et al. Incidence and impact of subclinical epileptiform activity in Alzheimer’s disease. Ann Neurol. 2016; 80(6): 858-870. - PMC - PubMed
1. Sanchez PE, Zhu L, Verret L, et al. Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer’s disease model. Proc Natl Acad Sci U S A. 2012; 109(42): E2895-E2903. - PMC - PubMed